Publications by authors named "Peter Goadsby"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

3

Total Likes

14

Extended Reach

18,799

Social Features

9
E
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2-4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial.
Cristina Tassorelli, Amaal J Starling, Susanne F Awad, Xin Ying Lee, Line Pickering Boserup, Peter J Goadsby

Eur J Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans.
Peter J Goadsby, Alexandra J Sinclair, Shazia K Afridi, Christian Lucas, Jerôme Mawet

Neurol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgias.
Marta Vila-Pueyo, Peter J Goadsby, Kirk W Johnson, Philip R Holland

Headache· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline.
Peter J Goadsby, Alexander Feoktistov, Magdalena Anitescu, Miles Day, Peter Staats

Pain Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What's a migraine day? Analysis of the variety in the definition of a migraine day across phase III trials with drugs targeting the CGRP pathway.
Luna De Loose, Koen Paemeleire, Peter J Goadsby, Antoinette MaassenVanDenBrink, Jan Versijpt

Cephalalgia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches.
Maria Dolores Villar-Martinez, Ahmed Abdalla, Peter J Goadsby

Curr Opin Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hallmarks of primary headache: part 3 - cluster headache.
Gianluca Coppola, Marco Antônio Arruda, Messoud Ashina, Mads Barloese, Andrea Carmine Belin, Peter J Goadsby

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary stabbing headache in a tertiary headache centre.
Simone Braca, Amy Gimson, Peter J Goadsby

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating associations of migraine-related vertigo.
Nazia Karsan, Nicolas Vandenbussche, Robyn Jenia-Wilcha, Pubudu Amarasena, Pannathat Soontrapa, Peter J Goadsby

Headache· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Classification of Headache Disorders 4: Classification committee comments on differentiating primary from secondary headache and recognizing "medication overuse".
Todd J Schwedt, Stefan Evers, Amy A Gelfand, Richard B Lipton, Arne May, Peter J Goadsby

Cephalalgia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral rimegepant as a preventive treatment of migraine: a plain language summary of a clinical study.
Robert Croop, Richard B Lipton, David Kudrow, Lisa Kamen, Charles M Conway, Peter J Goadsby

Pain Manag· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromodulation in trigeminal autonomic cephalalgias: 11-year experience of non-invasive vagus nerve stimulation.
Catarina S Fernandes, Usman Ashraf, Peter J Goadsby

Cephalalgia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome.
Simone Braca, Viviana Santoro, Gabriele Sebastianelli, Christoph J Schankin, Peter J Goadsby

Cephalalgia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine: advances in treatment.
Usman Ashraf, Peter J Goadsby

Trends Mol Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial.
Peter J Goadsby, Jessica Ailani, David W Dodick, Amaal J Starling, Chengcheng Liu

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical Trial.
Rigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, Andrew Charles, Peter J Goadsby

JAMA Neurol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cranial autonomic symptoms as a protective mechanism in patients with chronic migraine: A cross-sectional study.
Maria Dolores Villar-Martinez, Peter J Goadsby

Cephalalgia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in understanding migraine for the development of novel pharmacotherapies: the use of human provocation migraine models.
Nazia Karsan, Sina Marzoughi, Peter J Goadsby

Expert Opin Pharmacother· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rimegepant orally disintegrating tablet for acute treatment of migraine: a plain language summary of a clinical study.
Robert Croop, Peter J Goadsby, David A Stock, Charles M Conway, Micaela Forshaw

Pain Manag· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.
María Clara García-Castillo, Álvaro Sierra-Mencía, Edoardo Caronna, Daniel Toledo-Alfocea, Alex Jaimes, Peter J Goadsby

J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.
Cristina Tassorelli, Rigmor H Jensen, Peter J Goadsby, Andrew C Charles, Stewart J Tepper

Lancet Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amylin and the amylin receptors in migraine: Is there another pathway to target?
David Moreno-Ajona, Helin Gosalia, Jan Hoffmann, Peter J Goadsby

Cephalalgia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of premonitory spontaneous and nitroglycerin triggered symptoms among patients with cluster headache and migraine.
Alicia Gonzalez-Martinez, Diana Y Wei, Nazia Karsan, Karthik Nagaraj, Helin Gosalia, Peter J Goadsby

Cephalalgia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutamate as a Therapeutic Substrate in Migraine.
Nazia Karsan, Luiza Bastos Alves, Peter J Goadsby

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis